Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study

Volkan Turan, Ebru Kaya Mutlu, Ulas Solmaz, Atalay Ekin, Ozge Tosun, Gokhan Tosun, Emre Mat, Cenk Gezer, Mehtap Malkoc, Volkan Turan, Ebru Kaya Mutlu, Ulas Solmaz, Atalay Ekin, Ozge Tosun, Gokhan Tosun, Emre Mat, Cenk Gezer, Mehtap Malkoc

Abstract

[Purpose] The short-term effects of structured exercise on the anthropometric, cardiovascular, and metabolic parameters of non-overweight women diagnosed with polycystic ovary syndrome were evaluated. [Subjects and Methods] Thirty women with a diagnosis of polycystic ovary syndrome were prospectively randomized to either a control group (n=16) or a training group (n=14) for a period of 8 weeks. Anthropometric, cardiovascular, and metabolic parameters and hormone levels were measured and compared before and after the intervention. [Results] Waist and hip measurements (anthropometric parameters); diastolic blood pressure; respiratory rate (cardiovascular parameters); levels of low-density lipoprotein cholesterol, total cholesterol, fasting glucose, and fasting insulin; and the homeostasis model assessment of insulin resistance index (metabolic parameters) were significantly lower in the training group after 8 weeks of exercise compared to the baseline values. After exercise, the training group had significantly higher oxygen consumption and high-density lipoprotein levels and significantly shorter menstrual cycle intervals. The corresponding values for controls did not significantly differ between the start and end of the 8-week experiment. [Conclusion] Short-term regular exercise programs can lead to improvements in anthropometric, cardiovascular, and metabolic parameters of non-overweight women with polycystic ovary syndrome.

Keywords: Exercise; Non-overweight; Polycystic ovary syndrome.

Figures

Fig. 1.
Fig. 1.
Study flow chart

References

    1. Ehrmann DA: Polycystic ovary syndrome. N Engl J Med, 2005, 352: 1223–1236.
    1. Sheehan MT: Polycystic ovarian syndrome: diagnosis and management. Clin Med Res, 2004, 2: 13–27.
    1. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, et al. : Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab, 2007, 18: 280–285.
    1. Moran LJ, Lombard CB, Lim S, et al. : Polycystic ovary syndrome and weight management. Womens Health (Lond Engl), 2010, 6: 271–283.
    1. Thomson RL, Buckley JD, Noakes M, et al. : The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2008, 93: 3373–3380.
    1. Lee HC, Heo T: Effects of exercise therapy on blood lipids of obese women. J Phys Ther Sci, 2014, 26: 1675–1677.
    1. Tamura T, Kida K, Seki T, et al. : Study of the relationship between exercise therapy and diet therapy in type 2 diabetes mellitus patients. J Phys Ther Sci, 2011, 23: 485–488.
    1. Li L, Chen X, He Z, et al. : Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol, 2012, 25: 390–395.
    1. Thomson RL, Buckley JD, Moran LJ, et al. : Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. BJOG, 2009, 116: 1242–1250.
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004, 81: 19–25.
    1. Carmina E, Orio F, Palomba S, et al. : Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril, 2005, 84: 413–419.
    1. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab, 1961, 21: 1440–1447.
    1. Kervio G, Carre F, Ville NS: Reliability and intensity of the six-minute walk test in healthy elderly subjects. Med Sci Sports Exerc, 2003, 35: 169–174.
    1. Saglam M, Arikan H, Savci S, et al. : International physical activity questionnaire: reliability and validity of the Turkish version. Percept Mot Skills, 2010, 111: 278–284.
    1. Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med, 1970, 2: 92–98.
    1. Robertson RJ, Goss FL, Rutkowski J, et al. : Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc, 2003, 35: 333–341.
    1. Lee Y, Jun I, Ju S: Impact of home exercise training on patients with acute myocardial infarction. J Phys Ther Sci, 2012, 24: 743–745.
    1. Kim DY, Seo BD, Kim DJ: Effect of walking exercise on changes in cardiorespiratory fitness, metabolic syndrome markers, and high-molecular-weight adiponectin in obese middle-aged women. J Phys Ther Sci, 2014, 26: 1723–1727.
    1. Yagura C, Takamura N, Goto Y, et al. : Cardiorespiratory fitness and metabolic markers in healthy young adult men. J Phys Ther Sci, 2011, 23: 845–849.
    1. Fux Otta C, Wior M, Iraci GS, et al. : Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol, 2010, 26: 173–178.
    1. Harborne L, Fleming R, Lyall H, et al. : Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet, 2003, 361: 1894–1901.
    1. Nestler JE: Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med, 2008, 358: 47–54.
    1. Açbay O, Gündoğdu S: Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril, 1996, 65: 946–949.
    1. Ehrmann DA, Cavaghan MK, Imperial J, et al. : Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997, 82: 524–530.
    1. Orio F, Giallauria F, Palomba S, et al. : Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf), 2008, 68: 976–981.
    1. Giallauria F, Palomba S, Maresca L, et al. : Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf), 2008, 69: 792–798.
    1. Vigorito C, Giallauria F, Palomba S, et al. : Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2007, 92: 1379–1384.
    1. Liao LM, Nesic J, Chadwick PM, et al. : Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation. Gynecol Endocrinol, 2008, 24: 555–561.
    1. Panidis D, Farmakiotis D, Rousso D, et al. : Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril, 2008, 89: 899–906.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅